Skip to main content
. 2023 Aug 21;109(4):761–769. doi: 10.4269/ajtmh.23-0280

Figure 1.

Figure 1.

Data extraction process for (A) review of serious adverse effects (SAEs) in clinical trials and (B) review of severe primaquine-associated hemolysis. AL = artemether-lumefantrine; CQ = chloroquine; PQ = primaquine; WWARN = Worldwide Antimalarial Resistance Network.